Cargando…

Immunotherapy in Head and Neck Cancer When, How, and Why?

Head and neck cancer (HNC) is one of the most common cancers worldwide. Alcohol and tobacco consumption, besides viral infections, are the main risk factors associated with this cancer. When diagnosed in advanced stages, HNC patients present a higher probability of recurrence or metastasising. The c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Daniela, Martins, Diana, Mendes, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495940/ https://www.ncbi.nlm.nih.gov/pubmed/36140252 http://dx.doi.org/10.3390/biomedicines10092151

Ejemplares similares

Immunotherapy in Breast Cancer: When, How, and What Challenges?
por: Henriques, Beatriz, et al.
Publicado: (2021)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Cancer-associated thrombosis: the when, how and why
por: Fernandes, Caio J., et al.
Publicado: (2019)

Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review
por: Strojan, Primož, et al.
Publicado: (2021)

Primary Extracranial Meningiomas of the Head and Neck
por: Umana, Giuseppe Emmanuele, et al.
Publicado: (2021)

Neurophobia: why, how much, consequences and solutions
por: Hernando-Requejo, Virgilio
Publicado: (2020)

The Economic Burden of Head and Neck Cancer: A Systematic Literature Review
por: Wissinger, Erika, et al.
Publicado: (2014)

The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review
por: Mariani, Marco, et al.
Publicado: (2021)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Preventive measures for the progression of dysphagia in patients with cancer of head and neck subjected to radiotherapy: a systematic review with meta-analysis
por: Beuren, Amanda Guterres, et al.
Publicado: (2023)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Oral Microbiota—A New Frontier in the Pathogenesis and Management of Head and Neck Cancers
por: Metsäniitty, Marjut, et al.
Publicado: (2021)

Nasal Cytology Changes in Head and Neck Cancer Treatment: A Systemic Review
por: Riva, Giuseppe, et al.
Publicado: (2023)

Updated Systematic Review on the Role of Brain Invasion in Intracranial Meningiomas: What, When, Why?
por: Brunasso, Lara, et al.
Publicado: (2022)

Birth Control: Why, When and How?
Publicado: (1940)

Calcifediol: Why, When, How Much?
por: Donati, Simone, et al.
Publicado: (2023)

Milk-Derived Proteins and Peptides in Head and Neck Carcinoma Treatment
por: Wang, Theresa, et al.
Publicado: (2022)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
por: Julian, Ricklie, et al.
Publicado: (2021)

Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer
por: Rao, Yuan James, et al.
Publicado: (2023)

Systematic Review of Nutrition Interventions to Improve Short Term Outcomes in Head and Neck Cancer Patients
por: Leis, Claire, et al.
Publicado: (2023)

Current role of artificial intelligence in head and neck cancer surgery: a systematic review of literature
por: Loperfido, Antonella, et al.
Publicado: (2023)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Current Advances in Robotics for Head and Neck Surgery—A Systematic Review
por: Boehm, Felix, et al.
Publicado: (2021)

Precision Medicine on the Effects of Microbiota on Head–Neck Diseases and Biomarkers Diagnosis
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023)

N-acetylcysteine in COPD: why, how, and when?
por: Sanguinetti, Claudio M.
Publicado: (2016)

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
por: Fasano, Morena, et al.
Publicado: (2021)

Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review
por: Kouri, Maria, et al.
Publicado: (2022)

Cognitive Decline following Radiotherapy of Head and Neck Cancer: Systematic Review and Meta-Analysis of MRI Correlates
por: Voon, Noor Shatirah, et al.
Publicado: (2021)

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review
por: Perrotti, Vittoria, et al.
Publicado: (2021)

Immunotherapy of Head and Neck Cancer: Current and Future Considerations
por: Rapidis, Alexander D., et al.
Publicado: (2009)

Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review
por: Schlachtenberger, Georg, et al.
Publicado: (2022)

A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need
por: Filippini, Daria Maria, et al.
Publicado: (2023)

Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
por: Rooney, Michael K., et al.
Publicado: (2023)

A review on the advances and challenges of immunotherapy for head and neck cancer
por: Cheng, Gang, et al.
Publicado: (2021)

Epigenetic modulation of immunotherapy and implications in head and neck cancer
por: Zhou, Liye, et al.
Publicado: (2021)

ESSKA consensus initiative: why, when and how?
por: Beaufils, Philippe, et al.
Publicado: (2023)

A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy
por: Chin, Re-I, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufgkvmou6n7pa6fkjbuat49r8k